High HIV viral suppression among adults receiving WHO-recommended first-line dolutegravir-based antiretroviral therapy in low- and middle-income countries: a systematic review and meta-analysis of programmatic evidence.
Saved in:
| Title: | High HIV viral suppression among adults receiving WHO-recommended first-line dolutegravir-based antiretroviral therapy in low- and middle-income countries: a systematic review and meta-analysis of programmatic evidence. |
|---|---|
| Authors: | Girón-Callejas, Amalia1 (AUTHOR) amalia.giron-callejas21@alumni.imperial.ac.uk, Lorenzana, Rolando2 (AUTHOR) rl3246@cumc.columbia.edu, Pickles, Michael3,4 (AUTHOR) m.pickles@imperial.ac.uk, Inzaule, Seth5 (AUTHOR) s.inzaule@aighd.org, Jordan, Michael R.6,7,8 (AUTHOR) michael.jordan@tufts.edu, Diaz, Sheilee9 (AUTHOR) sldiaz@uvg.edu.gt, Vrinten, Charlotte1 (AUTHOR) c.vrinten@imperial.ac.uk |
| Source: | AIDS Research & Therapy. 9/26/2025, Vol. 22 Issue 1, p1-16. 16p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
